Numerous reports indicate that NK cell immunotherapy is an effective therapeutic approach for treating hematological malignancies, but shows limited effects against solid tumors. These data show that eNK cell immunotherapy could be a promising treatment strategy for ovarian cancers, including solid tumors and ascites.
Countstar Connection
The researchers measured cell numbers in the study's cell samples with Countstar (model not specified) during quality assessment in the 2021 Cancers study.
